Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Combination of Covid-19 and flu linked to greater risk of severe disease, death

Adults in hospital who have Covid-19 and the flu at the same time are at much greater risk of severe disease and death compared with patients who have Covid-19 alone or with other viruses, research shows.

27 Mar 2022

New method for generating binding proteins solves a long-standing challenge in drug development

A team of scientists has created a powerful new method for generating protein drugs. Using computers, they designed molecules that can target important proteins in the body, such as the insulin receptor, as well as vulnerable proteins on the surface of viruses.

25 Mar 2022

Novel SARS-CoV-2 strains found to have low impact on CD8 T lymphocytes

Researchers investigated the impact of mutations in the SARS-CoV-2 variants of interest and variants of concern on the properties of the cluster of differentiation 8 T lymphocytes.

25 Mar 2022

Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction

A new study has focussed on screening and identification of possible SMIs of this PPI for COVID-19.

25 Mar 2022

Study evaluates the clinical accuracy of two FDA-approved rapid antigen tests across SARS-CoV-2 variants

Researchers evaluated clinical accuracy and analytical detection capabilities of the two US Food and Drug Administration-approved rapid antigen tests across SARS-CoV-2 variants.

25 Mar 2022

The intercontinental spread of high-pathogenic avian influenza A (H5N1) virus

Researchers aim to better understand the landscape movement of the avian influenza virus.

24 Mar 2022

Shorter course of antibiotics associated with fewer antibiotic resistance genes

Antibiotic resistance is a growing problem worldwide that threatens the efficacy of available treatments and can lead to extended hospital stays and increased mortality.

24 Mar 2022

Prevalence of organ impairment in Long COVID patients 6 and 12 months after initial symptoms

Researchers assessed the prevalence of organ impairment in long COVID six months and a year post-COVID-19 at London and Oxford.

24 Mar 2022

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Researchers assessed the changes in the immunoglobulin titers against the receptor-binding domain of the spike protein of SARS-CoV-2 post-vaccination and natural SARS-CoV-2 infection in healthcare workers of Boston.

24 Mar 2022

Breathlessness and fatigue most common in self reported long-COVID

A new systematic review and meta-analysis posted to the medRxiv* preprint server has focussed on investigating the respiratory outcomes and functional recovery of patients eight weeks post-hospitalization with COVID-19 disease.

24 Mar 2022

SARS-CoV-2 is evolving adaptively in multiple regions of the genome

Scientists from the United States have recently assessed the evolutionary success of mutations accumulated across severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome. They have observed that the positively-selected mutations in the viral spike S1 subunit are primarily responsible for adaptive evolution. This indicates that the virus may undergo antigenic drift.

23 Mar 2022

New therapy makes immunologically 'cold' tumors hot enough for immune attack

Pancreatic cancer is notoriously difficult to cure or even treat. Now, a new strategy devised by scientists at Albert Einstein College of Medicine has succeeded in making pancreatic tumors visible to the immune systems of mice and vulnerable to immune attack, reducing cancer metastases by 87%.

23 Mar 2022

Scientists develop first drug to treat uncontrolled secretion of mucins in the airways

A multicenter research team co-led by The University of Texas MD Anderson Cancer Center developed the first drug to treat the uncontrolled secretion of mucins in the airways, which causes potentially life-threatening symptoms in millions of Americans with asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF), as well as lung disease resulting from cancer and cancer treatment.

23 Mar 2022

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Combination of Covid-19 and flu linked to greater risk of severe disease, death

New method for generating binding proteins solves a long-standing challenge in drug development

Novel SARS-CoV-2 strains found to have low impact on CD8 T lymphocytes

Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction

Study evaluates the clinical accuracy of two FDA-approved rapid antigen tests across SARS-CoV-2 variants

The intercontinental spread of high-pathogenic avian influenza A (H5N1) virus

Shorter course of antibiotics associated with fewer antibiotic resistance genes

Prevalence of organ impairment in Long COVID patients 6 and 12 months after initial symptoms

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Breathlessness and fatigue most common in self reported long-COVID

SARS-CoV-2 is evolving adaptively in multiple regions of the genome

New therapy makes immunologically 'cold' tumors hot enough for immune attack

Scientists develop first drug to treat uncontrolled secretion of mucins in the airways

Study confirms no preexisting B-cell immunity against SARS-CoV-2 in pre-pandemic samples

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

Discovery of helpful proteins in the lung could lead to new treatment for respiratory failure

SARS-CoV-2 mRNA vaccines may prevent COVID-19-associated mechanical ventilation and death

Umbrella analysis of the effect of renin-angiotensin-aldosterone system inhibitors on COVID-19 related outcomes

Genomic sequencing reveals unique pattern of SARS-CoV-2 Epsilon emergence in Alaska

Detection of immune and clotting dysfunction in plasma and saliva after SARS-CoV-2 infection

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in